Gene · 3274
Papers2,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis. | Eur J Clin Pharmacol | 2022 | 34817624 | PubTator, text mining | PubMed |
| Loss of H2R Signaling Disrupts Neutrophil Homeostasis and Promotes Inflammation-Associated Colonic Tumorigenesis in Mice. | Cell Mol Gastroenterol Hepatol | 2022 | 34781022 | PubTator, text mining | PubMed |
| Histamine Deficiency Promotes Myofibroblasts Transformation from HDC-Expressing CD11b+ Myeloid Cells in Injured Hearts Post Myocardial Infarction. | J Cardiovasc Transl Res | 2022 | 34734351 | PubTator, text mining | PubMed |
| Evaluating anti-coronavirus activity of some phosphoramides and their influencing inhibitory factors using molecular docking, DFT, QSAR, and NCI-RDG studies. | J Mol Struct | 2022 | 34538931 | PubTator, text mining | PubMed |
| Changes in Histaminergic System in Neuropsychiatric Disorders and the Potential Treatment Consequences. | Curr Neuropharmacol | 2022 | 34521328 | PubTator, text mining | PubMed |
| An altered sputum macrophage transcriptome contributes to the neutrophilic asthma endotype. | Allergy | 2022 | 34510493 | PubTator, text mining | PubMed |
| Histamine-4 Receptor: Emerging Target for the Treatment of Neurological Diseases. | Curr Top Behav Neurosci | 2022 | 34432256 | PubTator, text mining | PubMed |
| Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. | Nat Rev Drug Discov | 2022 | 34417579 | PubTator, text mining | PubMed |
| Sex Differences in Molecular Rhythms in the Human Cortex. | Biol Psychiatry | 2022 | 33934884 | PubTator, text mining | PubMed |
| Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19. | J Biomol Struct Dyn | 2022 | 33491579 | PubTator, text mining | PubMed |
| Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation. | Front Mol Med | 2021 | 39087081 | PubTator, text mining | PubMed |
| Liver cell circuits and therapeutic discovery for advanced liver disease and cancer. | C R Biol | 2021 | 35786628 | PubTator, text mining | PubMed |
| TMSOTf-catalyzed synthesis of trisubstituted imidazoles using hexamethyldisilazane as a nitrogen source under neat and microwave irradiation conditions. | RSC Adv | 2021 | 35480777 | PubTator, text mining | PubMed |
| Regioselective Pd-catalyzed α-alkylation of furans using alkyl iodides. | RSC Adv | 2021 | 35423913 | PubTator, text mining | PubMed |
| Determination of N-nitrosodimethylamine in Ranitidine Dosage Forms by ESI-LC-MS/MS; Applications for Routine Laboratory Testing. | Iran J Pharm Res | 2021 | 35194444 | PubTator, text mining | PubMed |
| Packaging and Delivery of Asthma Therapeutics. | Pharmaceutics | 2021 | 35056988 | PubTator, text mining | PubMed |
| New Potential of Roxatidine Acetate Hydrochloride on Atopic Dermatitis Mouse Model, Human Keratinocytes, and Human Skin Equivalent Model. | Front Pharmacol | 2021 | 35002730 | PubTator, text mining | PubMed |
| The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions. | Front Pharmacol | 2021 | 34987383 | PubTator, text mining | PubMed |
| Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise. | Int J Environ Res Public Health | 2021 | 34948944 | PubTator, text mining | PubMed |
| Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors. | Proc Natl Acad Sci U S A | 2021 | 34916293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3274/papers?page=17